Literature DB >> 22554795

Cancer stem cells and epithelial-mesenchymal transition: concepts and molecular links.

Christina Scheel1, Robert A Weinberg.   

Abstract

The epithelial-mesenchymal transition (EMT) confers mesenchymal properties on epithelial cells and has been closely associated with the acquisition of aggressive traits by carcinoma cells. EMT programs are orchestrated by a set of pleiotropically acting transcription factors (TFs). The actions of these EMT-TFs enable the early steps of metastasis: local invasion and subsequent dissemination of carcinoma cells to distant sites. However, in most malignancies, the subsequent outgrowth of micrometastatic deposits into macroscopic metastases has the greatest impact on clinical progression. Such metastatic "colonization" reflects the ability of disseminated tumor cells to adapt to a foreign tissue microenvironment. The outgrowth of a metastasis is also thought to be associated with self-renewal, the defining cellular trait of cancer stem cells (CSCs), also termed tumor-initiating cells. Importantly, molecular links between EMT-TFs and self-renewal have emerged, suggesting that EMT programs play critical roles both early and late in the metastatic cascade. The genetic and epigenetic mechanisms that regulate the activation of EMT-TFs and the traits they induce are areas under intensive investigation. Such studies may provide new opportunities for therapeutic intervention and help to overcome tumor heterogeneity and therapeutic resistance.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22554795      PMCID: PMC6220425          DOI: 10.1016/j.semcancer.2012.04.001

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  88 in total

Review 1.  Tumor patterning: analogies of neoplastic morphogenesis with embryogenesis.

Authors:  T Kirchner; T Brabletz
Journal:  Verh Dtsch Ges Pathol       Date:  2000

Review 2.  Molecular signaling of the epithelial to mesenchymal transition in generating and maintaining cancer stem cells.

Authors:  Gaoliang Ouyang; Zhe Wang; Xiaoguang Fang; Jia Liu; Chaoyong James Yang
Journal:  Cell Mol Life Sci       Date:  2010-03-18       Impact factor: 9.261

3.  Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells.

Authors:  Yohei Shimono; Maider Zabala; Robert W Cho; Neethan Lobo; Piero Dalerba; Dalong Qian; Maximilian Diehn; Huiping Liu; Sarita P Panula; Eric Chiao; Frederick M Dirbas; George Somlo; Renee A Reijo Pera; Kaiqin Lao; Michael F Clarke
Journal:  Cell       Date:  2009-08-07       Impact factor: 41.582

4.  The morphological and molecular features of the epithelial-to-mesenchymal transition.

Authors:  Gema Moreno-Bueno; Héctor Peinado; Patricia Molina; David Olmeda; Eva Cubillo; Vanesa Santos; José Palacios; Francisco Portillo; Amparo Cano
Journal:  Nat Protoc       Date:  2009-10-15       Impact factor: 13.491

Review 5.  The ins and outs of the epithelial to mesenchymal transition in health and disease.

Authors:  M Angela Nieto
Journal:  Annu Rev Cell Dev Biol       Date:  2011-07-08       Impact factor: 13.827

Review 6.  Opinion: migrating cancer stem cells - an integrated concept of malignant tumour progression.

Authors:  Thomas Brabletz; Andreas Jung; Simone Spaderna; Falk Hlubek; Thomas Kirchner
Journal:  Nat Rev Cancer       Date:  2005-09       Impact factor: 60.716

7.  TGF-beta-FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemia.

Authors:  Kazuhito Naka; Takayuki Hoshii; Teruyuki Muraguchi; Yuko Tadokoro; Takako Ooshio; Yukio Kondo; Shinji Nakao; Noboru Motoyama; Atsushi Hirao
Journal:  Nature       Date:  2010-02-04       Impact factor: 49.962

Review 8.  Understanding the cancer stem cell.

Authors:  S Bomken; K Fiser; O Heidenreich; J Vormoor
Journal:  Br J Cancer       Date:  2010-07-27       Impact factor: 7.640

9.  Biological and molecular heterogeneity of breast cancers correlates with their cancer stem cell content.

Authors:  Salvatore Pece; Daniela Tosoni; Stefano Confalonieri; Giovanni Mazzarol; Manuela Vecchi; Simona Ronzoni; Loris Bernard; Giuseppe Viale; Pier Giuseppe Pelicci; Pier Paolo Di Fiore
Journal:  Cell       Date:  2010-01-08       Impact factor: 41.582

10.  Illegitimate WNT pathway activation by beta-catenin mutation or autocrine stimulation in T-cell malignancies.

Authors:  Richard W J Groen; Monique E C M Oud; Esther J M Schilder-Tol; Marije B Overdijk; Derk ten Berge; Roel Nusse; Marcel Spaargaren; Steven T Pals
Journal:  Cancer Res       Date:  2008-09-01       Impact factor: 12.701

View more
  405 in total

1.  Epithelial-mesenchymal transition leads to crizotinib resistance in H2228 lung cancer cells with EML4-ALK translocation.

Authors:  Hyeong Ryul Kim; Woo Sung Kim; Yun Jung Choi; Chang Min Choi; Jin Kyung Rho; Jae Cheol Lee
Journal:  Mol Oncol       Date:  2013-08-20       Impact factor: 6.603

Review 2.  The Multifaceted Role of HSF1 in Tumorigenesis.

Authors:  Milad J Alasady; Marc L Mendillo
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

3.  Piperlongumine inhibits cancer stem cell properties and regulates multiple malignant phenotypes in oral cancer.

Authors:  Yin-Ju Chen; Chia-Chun Kuo; Lai-Lei Ting; Long-Sheng Lu; Ya-Ching Lu; Ann-Joy Cheng; Yun-Tien Lin; Chien-Ho Chen; Jo-Ting Tsai; Jeng-Fong Chiou
Journal:  Oncol Lett       Date:  2017-11-24       Impact factor: 2.967

Review 4.  Metal carcinogen exposure induces cancer stem cell-like property through epigenetic reprograming: A novel mechanism of metal carcinogenesis.

Authors:  Zhishan Wang; Chengfeng Yang
Journal:  Semin Cancer Biol       Date:  2019-01-11       Impact factor: 15.707

5.  PD-L1 expression is regulated by both DNA methylation and NF-kB during EMT signaling in non-small cell lung carcinoma.

Authors:  A Asgarova; K Asgarov; Y Godet; P Peixoto; A Nadaradjane; M Boyer-Guittaut; J Galaine; D Guenat; V Mougey; J Perrard; J R Pallandre; A Bouard; J Balland; C Tirole; O Adotevi; E Hendrick; M Herfs; P F Cartron; C Borg; E Hervouet
Journal:  Oncoimmunology       Date:  2018-02-01       Impact factor: 8.110

6.  5-Fluorouracil may enrich cancer stem cells in canine mammary tumor cells in vitro.

Authors:  Bin Zhou; Yipeng Jin; Di Zhang; Degui Lin
Journal:  Oncol Lett       Date:  2018-03-15       Impact factor: 2.967

Review 7.  Cancer stem cells: Regulation programs, immunological properties and immunotherapy.

Authors:  Dingxiao Zhang; Dean G Tang; Kiera Rycaj
Journal:  Semin Cancer Biol       Date:  2018-05-09       Impact factor: 15.707

8.  Malignant Pleural Effusion and ascites Induce Epithelial-Mesenchymal Transition and Cancer Stem-like Cell Properties via the Vascular Endothelial Growth Factor (VEGF)/Phosphatidylinositol 3-Kinase (PI3K)/Akt/Mechanistic Target of Rapamycin (mTOR) Pathway.

Authors:  Tao Yin; Guoping Wang; Sisi He; Guobo Shen; Chao Su; Yan Zhang; Xiawei Wei; Tinghong Ye; Ling Li; Shengyong Yang; Dan Li; Fuchun Guo; Zeming Mo; Yang Wan; Ping Ai; Xiaojuan Zhou; Yantong Liu; Yongsheng Wang; Yuquan Wei
Journal:  J Biol Chem       Date:  2016-10-18       Impact factor: 5.157

9.  Stem cell-like ALDH(bright) cellular states in EGFR-mutant non-small cell lung cancer: a novel mechanism of acquired resistance to erlotinib targetable with the natural polyphenol silibinin.

Authors:  Bruna Corominas-Faja; Cristina Oliveras-Ferraros; Elisabet Cuyàs; Antonio Segura-Carretero; Jorge Joven; Begoña Martin-Castillo; Enrique Barrajón-Catalán; Vicente Micol; Joaquim Bosch-Barrera; Javier A Menendez
Journal:  Cell Cycle       Date:  2013-09-17       Impact factor: 4.534

Review 10.  Sheep, wolf, or werewolf: cancer stem cells and the epithelial-to-mesenchymal transition.

Authors:  Jeffrey T Chang; Sendurai A Mani
Journal:  Cancer Lett       Date:  2013-03-14       Impact factor: 8.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.